{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Psychopharmacological Interventions in Autism Spectrum Disorder ((Non-Physician Credit))
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
The certificate for this activity is for NON-PHYSICIANS.In this literature review, the authors discuss the various classes of psychotropic medications that may be prescribed to patients with autism spectrum disorders (ASD). Those with ASD may present with a variety of comorbid symptoms, such as psychiatric comorbidity, attention-deficit/hyperactivity disorder, and intellectual disability. This article analyzes literature related to each class of psychotropic medication and the symptoms that medication may be able to improve. For example, the discussion on atypical antipsychotics notes that risperidone has efficacy in treating severe irritability associated with ASD. The authors conclude that more controlled trials are needed to create guidelines for use of all classes of psychotropic medications in ASD and recommend a cautious approach in prescribing these medications.Purpose of Activity
To review the literature pertaining to the use of psychotropic medications in treating psychiatric symptoms in autism spectrum disorder.Learning Objectives
After completing this continuing education activity you will be able to:
- Prescribe the appropriate psychotropic medication to treat symptoms of ASD.
- Identify the side effects of the psychotropic medications used to treat ASD.
Disclosures
All faculty members and all LCMEI staff members in a position to control the content of this CME activity have disclosed that they and their spouse/life partners (if any) have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity.
The authors has disclosed that the U.S. Food and Drug Administration has not approved the use of all medications discussed in this article (with the exception for risperidone and aripiprazole) for the treatment in children with Autism Spectrum Disorders (ASD). Please consult the products' labeling for approved information.
Price:
$12.95
Credits:
- ACCME 1.0 CME
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Other Health Professional
Test Code: HRPN0214
Published: Mar/Apr 2014
Expires: 1/1/2026
Sources:
Harvard Review of Psychiatry
Required Passing Score: 7/10 (70%)
Categories:
Psychosocial/Psychiatric
Specialties:
Psychiatry